Johan Wedell-Wedellsborg, Director, 10% Owner at Y-mAbs Therapeutics, Inc. (YMAB), sold 990 shares at $27.75 ($27K) on 2019-08-22, disclosed to the SEC on 2019-08-26.
Open-market sale of $27k YMAB by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |